Amicus Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
526.98 |
626.61 |
756.61 |
903.92 |
1,088.10 |
1,272.38 |
| Przychód Δ r/r |
0.00% |
18.91% |
20.75% |
19.47% |
20.38% |
16.94% |
| Przychód (min) |
525.11 |
626.58 |
730.99 |
903.92 |
1,070.43 |
1,251.71 |
| Przychód (max) |
528.50 |
626.64 |
780.29 |
903.92 |
1,106.46 |
1,293.84 |
| EBITDA (średnia) |
-250.48 |
-297.83 |
-359.62 |
-429.64 |
-517.18 |
-604.77 |
| EBIT (średnia) |
-261.69 |
-311.16 |
-375.72 |
-448.87 |
-540.33 |
-631.84 |
| EBIT % |
-49.66% |
-49.66% |
-49.66% |
-49.66% |
-49.66% |
-49.66% |
| Zysk netto (średni) |
-38.10 |
-15.65 |
89.36 |
184.03 |
268.62 |
391.13 |
| Zysk netto % |
-7.23% |
-2.50% |
11.81% |
20.36% |
24.69% |
30.74% |
| EPS (średnia) |
-0.20 |
-0.05 |
0.28 |
0.57 |
0.88 |
1.28 |
| Liczba analityków (Przychody) |
9 |
7 |
12 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
6 |
5 |
7 |
7 |
5 |
2 |
| symbol |
FOLD |
FOLD |
FOLD |
FOLD |
FOLD |
FOLD |